Concepedia

Anthony R. Mato

AR

100

Publications

6.6K

Citations

36

H-Index

2007

Active since

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

University of Pennsylvania

Columbia University Irving Medical Center

Dana-Farber Cancer Institute

Fred Hutch Cancer Center

Anthony R. Mato is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, immunology, and oncology.

Top concepts

MedicineOncologyImmunologyHealthPathologyHematologyImmunotherapyCancer ResearchPharmacotherapyRadiation Oncology

Publications per year

2007–2024

100

Publications

100

Ibrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia

Tait D. Shanafelt, Xin V. Wang, Neil E. Kay et al. · New England Journal of Medicine · 2019 · 715 citations · Full text

Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia: Results of the First Randomized Phase III Trial

John C. Byrd, Peter Hillmen, Paolo Ghia et al. · Journal of Clinical Oncology · 2021 · 594 citations · Full text

Toxicities and outcomes of 616 ibrutinib-treated patients in the United States: a real-world analysis

Anthony R. Mato, Chadhi Nabhan, Meghan C. Thompson et al. · Haematologica · 2018 · 439 citations · Full text

Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study

Anthony R. Mato, Nirav N. Shah, Wojciech Jurczak et al. · The Lancet · 2021 · 432 citations · Full text

Phase 1/2, Lymphoid Neoplasia, Medicine +6

Outcomes of COVID-19 in patients with CLL: a multicenter international experience

Anthony R. Mato, Lindsey E. Roeker, Nicole Lamanna et al. · Blood · 2020 · 316 citations · Full text

Rows per page

1–5 of 100